Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs DISHMAN CARBOGEN AMCIS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA DISHMAN CARBOGEN AMCIS ALEMBIC PHARMA/
DISHMAN CARBOGEN AMCIS
 
P/E (TTM) x 32.5 -23.3 - View Chart
P/BV x 4.5 0.6 719.5% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALEMBIC PHARMA   DISHMAN CARBOGEN AMCIS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
DISHMAN CARBOGEN AMCIS
Mar-23
ALEMBIC PHARMA/
DISHMAN CARBOGEN AMCIS
5-Yr Chart
Click to enlarge
High Rs792201 393.5%   
Low Rs46380 578.8%   
Sales per share (Unadj.) Rs287.6153.9 186.9%  
Earnings per share (Unadj.) Rs17.4-1.9 -915.4%  
Cash flow per share (Unadj.) Rs31.416.0 196.3%  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs222.3370.6 60.0%  
Shares outstanding (eoy) m196.56156.78 125.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.20.9 238.8%   
Avg P/E ratio x36.1-74.0 -48.7%  
P/CF ratio (eoy) x20.08.8 227.3%  
Price / Book Value ratio x2.80.4 743.6%  
Dividend payout %46.00-   
Avg Mkt Cap Rs m123,40222,059 559.4%   
No. of employees `000NANA-   
Total wages/salary Rs m11,69110,353 112.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,52624,129 234.3%  
Other income Rs m30278 10.9%   
Total revenues Rs m56,55724,407 231.7%   
Gross profit Rs m6,7722,841 238.4%  
Depreciation Rs m2,7542,807 98.1%   
Interest Rs m502857 58.5%   
Profit before tax Rs m3,546-546 -649.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m126-248 -50.9%   
Profit after tax Rs m3,420-298 -1,147.6%  
Gross profit margin %12.011.8 101.8%  
Effective tax rate %3.645.4 7.8%   
Net profit margin %6.1-1.2 -489.9%  
BALANCE SHEET DATA
Current assets Rs m29,13919,184 151.9%   
Current liabilities Rs m16,40817,984 91.2%   
Net working cap to sales %22.55.0 453.0%  
Current ratio x1.81.1 166.5%  
Inventory Days Days1071 13.7%  
Debtors Days Days79 75.7%  
Net fixed assets Rs m31,49875,211 41.9%   
Share capital Rs m393314 125.4%   
"Free" reserves Rs m43,31257,783 75.0%   
Net worth Rs m43,70558,097 75.2%   
Long term debt Rs m010,467 0.0%   
Total assets Rs m60,63794,395 64.2%  
Interest coverage x8.10.4 2,223.0%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.90.3 364.7%   
Return on assets %6.50.6 1,092.3%  
Return on equity %7.8-0.5 -1,525.5%  
Return on capital %9.30.5 2,041.8%  
Exports to sales %46.40-   
Imports to sales %12.10-   
Exports (fob) Rs m26,210NA-   
Imports (cif) Rs m6,846NA-   
Fx inflow Rs m26,2103,980 658.5%   
Fx outflow Rs m6,846761 899.4%   
Net fx Rs m19,3643,219 601.5%   
CASH FLOW
From Operations Rs m7,2402,203 328.6%  
From Investments Rs m-4,476-4,485 99.8%  
From Financial Activity Rs m-2,6202,497 -104.9%  
Net Cashflow Rs m144216 66.8%  

Share Holding

Indian Promoters % 69.1 59.3 116.5%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 19.8 11.1 179.4%  
FIIs % 4.5 8.7 51.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 40.7 74.7%  
Shareholders   76,567 50,656 151.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs DISHMAN CARBOGEN AMCIS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs DISHMAN CARBOGEN AMCIS Share Price Performance

Period ALEMBIC PHARMA DISHMAN CARBOGEN AMCIS S&P BSE HEALTHCARE
1-Day -0.44% -1.97% 0.45%
1-Month 2.92% 3.94% 2.55%
1-Year 80.69% 58.90% 56.14%
3-Year CAGR -0.31% 15.75% 15.22%
5-Year CAGR 11.77% 0.31% 19.63%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the DISHMAN CARBOGEN AMCIS share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of DISHMAN CARBOGEN AMCIS the stake stands at 59.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of DISHMAN CARBOGEN AMCIS.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

DISHMAN CARBOGEN AMCIS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of DISHMAN CARBOGEN AMCIS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.